The Brazil market dominated the LAMEA Animal Sedative Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $8.28 millions by 2031. The Argentina market is showcasing a CAGR of 7.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 5.9% during (2024 - 2031).
Stringent regulatory standards in developed countries ensure the safety, efficacy, and ethical use of pharmaceutical products, including sedatives. Compliance with regulatory requirements is a critical factor influencing the adoption of sedatives, ensuring that veterinary practices adhere to approved protocols for animal care.
Cultural attitudes towards pets and animals play a role in adoption rates. Countries with a strong tradition of pet ownership and care tend to have higher adoption rates of sedatives for companion animals. In contrast, regions where livestock farming is predominant may focus more on sedatives for large animals in agricultural settings.
The large population of livestock in the UAE requires regular veterinary care for health maintenance, reproductive health, and disease prevention. According to the United Arab Emirates Ministry of climate change & environment, the United Arab Emirates has a significant wealth of livestock. The camel population of the nation stands at 450,000, whereas the estimated number of sheep and goat colonies is around 5 million.
Also, new vet clinics and pet beauty salons tripled during the same period. Future demand is strong, and the sector is expected to grow 87% in the next five years. The expansion of pet veterinary clinics in Brazil leads to increased access to veterinary care for companion animals. This includes routine check-ups, vaccinations, surgeries, dental procedures, and diagnostic tests, often requiring sedatives. Therefore, the high population of livestock and the increasing number of vet clinics in the region are driving the market's growth
List of Key Companies Profiled
- Koninklijke Philips N.V.
- Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Visiopharm A/S
- Paige AI, Inc.
- PathAI, Inc.
- Aiforia Technologies Plc
- Indica Labs, Inc.
- Optrascan, Inc. (Optra Ventures, LLC)
- MindPeak GmbH
Market Report Segmentation
By Route of Administration- Parenteral
- Oral
- Dogs
- Cats
- Horses
- Others
- Alpha-2 Adrenergic Receptor Agonists
- Phenothiazines
- Benzodiazepines
- Butyrophenones
- Others
- Hospitals
- Specialty Centers
- Surgical
- Diagnostic
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Companies Mentioned
- Zoetis, Inc.
- Virbac
- Dechra Pharmaceuticals PLC
- Merck & Co., Inc.
- Bimeda, Inc.
- Ouro Fino Saude Animal Participacoes S.A.
- vetcare. fi.
- Chanelle Pharma (Exponent)
- Randlab Australia Pty Ltd.
- Troy Laboratories Pty Ltd.
Methodology
LOADING...